PROF Positive Sentiment
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
Tuesday, April 29, 2025 BiopharmaWatch Research 1 min read Key Takeaway: The CAPTAIN randomized trial has revealed that MRI-guided TULSA significantly enhances the post-operative experience compared to robotic radical prostatectomy. This initial perioperative data suggests a promising alternative for patients undergoing prostate surgery. Profound Medical Corp. is at the forefront of this innovative approach.
Full Press Release Details
Latest News
Company Overview
Stock Snapshot
Email Alerts
Sign up today and receive company updates straight to your inbox.
Company
Profound Medical Corp. 2400 Skymark Avenue Unit 6 Mississauga, ON L4W 5K5 Canada
Transfer Agent
Computershare Trust Company, N.A. (U.S.) 118 Fernwood Avenue Edison, NJ 08837 United States of America T: 732-417-2700
TSX Trust Company (Canada) 301-100 Adelaide Street West Toronto, ON M5H 4H1 Canada T: 866-600-5869
Connect With Us